Pezadeftide

Hexima’s lead product, pezadeftide, is a topical antifungal treatment for onychomycosis or fungal nail infections.

Now Recruiting

Hexima is recruiting volunteers for clinical trials of pezadeftide. Click below to find out more and to register your interest.

ShareCafe Webinar Recording

Latest NailMail Newsletter

Our CEO, Michael Aldridge, spoke at the ShareCafe Hidden Gems Webinar on 21 May 2021. You may view the recording of the webinar below or download the presentation (pdf).

NailMail is Hexima’s regular quarterly newsletter to shareholders, investors and interested parties.

ShareCafe Webinar Recording

Our CEO, Michael Aldridge, spoke at the ShareCafe Hidden Gems Webinar on 21 May 2021. You may view the recording of the webinar below or download the presentation (pdf).

Latest NailMail Newsletter

NailMail is Hexima’s regular quarterly newsletter to shareholders, investors and interested parties.

External Links

Take a look at these useful links to learn more about our industry.

Australian Academy of Science
Australian Science Media Centre logo